Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts

American Journal of Pathology

Volumn 154, Issue 3, 1999, Pages 883-889

  Yoshimoto, Hiroshi ^a   Ishihara, Hiroshi ^a   Ohtsuru, Akira ^a   Akino, Kozo ^a   Murakami, Ryuichi ^a   Kuroda, Hiroaki ^a   Namba, Hiroyuki ^a   Ito, Masahiro ^a   Fujii, Tohru ^a   Yamashita, Shunichi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; SOMATOMEDIN C RECEPTOR; TYROSINE KINASE RECEPTOR;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FIBROBLAST CULTURE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KELOID; MITOGENESIS; PRIORITY JOURNAL; SKIN FIBROBLAST;

EID: 0032998930     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65335-7     Document Type: Article

References (32)

1. Tredget EE. Nedelec B. Scott PG. Ghahary A: Hypertrophic scars, keloids, and contractures: the cellular and molecular basis for therapy. Surg Clin North Am 1997, 77:701-730
2. Haisa M, Okochi H, Grotendorst GR: Elevated levels of PDGF-α receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J Invest Dermatol 1994, 103:560-563
3. Babu M, Diegelmann R, Oliver N: Keloid fibroblasts exhibit an altered response to TGF-β. J Invest Dermatol 1992, 99:650-655
4. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 1990, 61:203-212
5. Hanks SK, Quinn AM, Hunter T: The protein kinase family: conserved features and deduced phytogeny of the catalytic domains. Science 1988. 241:42-52
6. Tanaka K. Nagayama Y, Nakano T, Takamura N, Namba H, Fukada S, Kuma K, Yamashita S, Niwa M: Expression profile of zeceptor-type protein tyrosine kinase genes in the human thyroid. Endocrinology 1998, 139:852-858
7. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987, 47:3239-3245
8. Arakawa M, Hatamochi A. Takeda K. Ueki H: Increased collagen synthesis accompanying elevated m-RNA levels in cultured Werner's syndrome fibroblasts. J Invest Dermatol 1990. 94:187-190
9. Rudman SM, Philpott MP, Thomas GA, Kealey T: The role of IGF-I in human skin and its appendages: morphogen as well as mitogen? J Invest Dermatol 1997. 109:770-777
10. Isaksson OG, Ohlsson C, Nilsson A, Isgaard J, Lindahl A: Regulation of cartilage growth by growth hormone and insulin-like growth factor I. Pediatr Nephrol 1991, 5:451-453
11. Baker J, Liu JP. Robertson EJ, Efstratiadis A: Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993, 75: 73-82
12. Sara VR, Hall K: Insulin-like growth factors and their binding proteins. Physiol Rev 1990, 70:591-614
13. Edwall D, Schalling M, Jennische E. Norstedt G: Induction of insulin-like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology 1989, 124:820-825
14. Jennische E. Skottner A, Hansson HA: Satellite cells express the trophic factor IGF-I in regenerating skeletal muscle. Acta Physiol Scand 1987, 129:9-15
15. Hansson HA. Dahlin LB. Danielsen N. et al: Evidence indicating trophic importance of IGF-I in regenerating peripheral nerves. Acta Physiol Scand 1986, 126:609-614
16. Ghahary A, Shen YJ. Nedelec B, Scott PG, Tredget EE: Enhanced expression of mRNA for insulin-like growth factor-1 in post-burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem 1995. 148:25-32
17. Ghahary A, Shen YJ, Nedelec B, Wang R, Scott PG, Tredget EE: Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol 1996, 106:476-481
18. Gartner MH, Benson JD, Caldwell MD: Insulin-like growth factors I and II expression in the healing wound. J Surg Res 1992. 52:389-394
19. Ketchum LD, Cohen IK, Masters FW: Hypertrophic scars and keloids: a collective review. Plast Reconstr Surg 1974, 53:140-154
20. Copeland KC, Colletti RB, Devlin JT, McAuliffe TL: The relationship between insulin-like growth factor-I, adiposity, and aging. Metabolism 1990. 39:584-587
21. Baserga R: Oncogenes and the strategy of growth factors. Cell 1994, 79:927-930
22. Baserga R: The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 1995, 55:249-252
23. Macaulay VM: Insulin-like growth factors and cancer. Br J Cancer 1992. 65:311-320
24. Prager D, Li HL, Asa S, Melmed S: Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci USA 1994. 91:2181-2185
25. Trojan J, Johnson TR, Rudin SD. Ilan J, Tykocinski ML. Ilan J: Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 1993. 259:94-97
26. Pietrzkowski Z. Wernicke D, Porcu P, Jameson BA, Baserga R: Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1. Cancer Res 1992, 52:6447-6451
27. Sell C, Dumenil G, Deveaud C. Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A, Baserga R: Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cel Biol 1994, 14: 3604-3612
28. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A: Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72
29. Sell C, Baserga R, Rubin R: Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res 1995, 55:303-3016
30. Burfeind P, Chernicky CL. Rininsland F, Ilan J, Ilan J: Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci USA 1996. 93:7263-7268
31. Long L, Rubin R, Baserga R, Brodt P: Loss of the metastatic phenotype in murine carcinoma cells expressing an ant sense RNA to the insulin-like growth factor receptor. Cancer Res 1995, 55:1006-1009
32. Baxter RC: Insulin-lKe growth factor binding proteins in the human circulation: a review. Horm Res 1994, 42:140-144